▶주메뉴 바로가기
▶본문 바로가기
GC Pharma announced on April 4 that it has signed a deal with Clinigen KK in Japan to license out its Hunter syndrome treatment Hunterase ICV. Hunter syndrome is a rare genetic disorder that interfe...
Kolon Life Science announced on April 1 that it has decided to suspend sales of its new osteoarthritis drug Invossa. According to the company, the decision was made after the its US unit Kolon Tiss...
South Korea’s bio sector is gaining both attention and traction, with many claiming their successful global expansion. While not all of them can deliver on their word, Daewoong Pharmaceutical is on...
Celltrion ’s founder and Chairman Seo Jung-jin announced on March 26 that the company aims to begin selling its biosimilar Truxima in the US within the second half of this year. Seo -- who is in To...
National Pension Service has decided to oppose key proposals by Samsung Biologics ahead of the company’s scheduled shareholders meeting on March 22. The key proposals include approval of the financi...
SK Biopharmaceuticals, the new drug development unit of South Korea’s telecom-to-energy conglomerate SK Group, announced on March 21 that it has received marketing approval from the US Food and Drug ...
South Korea’s biotherapeutics firm SillaJen announced on March 20 that it has decided to secure additional funds worth 110 billion won ($97.31 million) through issuing convertible bonds. The compa...
Korean pharmaceutical companies have high hopes of leaping forward this year by boosting research and development to develop new drugs. According to a survey conducted by the Korea Pharmaceutical an...
South Korean drug maker Donga Pharmaceutical said on March 18 that it will roll out its diabetes drug Suganon in India next month. India-based pharmaceutical firm Alkem Laboratories won exclusive...
Several South Korean pharmaceutical companies have decided to make new facility investments in a bid to hone their competitiveness, industry sources said on March 18. The decisions, made at annua...
Prosecutors raided South Korea’s main stock exchange on March 15 as part of a probe into alleged accounting fraud by Samsung BioLogics. Investigators from the Seoul Central District Prosecutors’ ...
South Korean internet giant Naver said on March 15 that it has established a joint venture with Daewoong Pharmaceutical to provide medical data analysis services based on its artificial intellige...
Daewoong Pharmaceutical announced on March 14 that it is negotiating with Vietnam’s second-biggest drug maker Traphaco to expand its presence in the country. The South Korean firm acquired a 15 per...
SillaJen has delayed its board meeting, which was expected to confirm its decision for securing new funds worth around 220 billion won ($194.89 million), according to industry sources on March 14. ...
South Korea’s biotherapeutics company SillaJen ’s stock price fluctuated after a local news outlet reported that the future of its drug candidate Pexa-Vec was murky. Pexa-Vec, which is undergoing ...
[Market Close-up] S. Korean stock market recovers faster than other markets
One Equity Partners to unload Celltrion Healthcare stake at discount
Local telecom firms bid for fifth-largest cable TV operator Hyundai HCN
IBK fined $86m in US over mishandling anti-money laundering program
Acleda Bank lists on KRX-invested Cambodian stock exchange
Samsung Biologics bags CMO deals worth W468b
Tmon vows to turn profit by 10th anniversary
Macrogen’s COVID-19 test kit approved for export
May 28, 2020
![[ANALYSIS] Market upbeat on Daewoong’s prospects for this year](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=155&simg=/content/image/2019/03/27/20190327000790_p.jpg)
![[Market Close-up] S. Korean stock market recovers faster than other markets](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2020/05/27/20200527000702_0.jpg&md=20200527162557)
